Aldeyra's Reproxalap progresses towards FDA approval, with a potential $100M AbbVie deal. There’s still upside potential, ...

A custom scleral lens system improves visual acuity and comfort in patients with a variety of corneal conditions, research ...

The program allows patients to undergo genetic testing and high-resolution retinal imaging anonymously and provide insights ...

I was recently diagnosed with Type 2 diabetes. My health care professional shared that I’ll need to have regular eye exams in ...

Researchers link early cone dysfunction in RPGR-related retinal dystrophy to high myopia, with timing of degeneration ...

This discovery could make treatment for an eye disease affecting millions with diabetes more accessible and affordable.

A novel eye drop formulation shows antioxidant effects and may protect corneal epithelial cells, according to research presented at AOA 2025.

Ocular Therapeutix, Inc. (NASDAQ: OCUL, "Ocular"), a biopharmaceutical company committed to redefining the retina experience, announced the launch of ...

Night blindness is caused by vitamin A deficiency, congenital mutations, and other eye diseases. Learn about symptoms, causes ...

Nanoscope Therapeutics Inc., a biotechnology company committed to developing and commercializing novel gene-agnostic therapies for patients suffering severe vision loss from retinal degenerative ...

Our eyes are one of the most important organs of our body, and not only are they our tool to see the outside world, but they can also be a reflection of our health. Changes in our eyes are not always ...

Regulatory Clearances Support Glaukos' Plans to Advance and Accelerate its Interventional Glaucoma Initiatives Globally Marks the Company's First Regulatory Clearances Under the New EU Regulatory ...